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Abstract— Epigenetic aberrations have profound effects on 
phenotypic output. Genome-wide methylation alterations are 
inheritable to pass down the aberrations through multiple 
generations. We developed a statistical method, Genome-wide 
Identification of Significant Methylation Alteration, GISAIM, to 
study the significant transgenerational methylation changes. 
GISAIM finds the significant methylation aberrations that are 
inherited through multiple generations. In a concrete biological 
study, we investigated whether exposing pregnant rats (F0) to a 
high fat (HF) diet throughout pregnancy or ethinyl-estradiol 
(EE2)-supplemented diet during gestation days 14-20 affects 
carcinogen-induced mammary cancer risk in daughters (F1), 
granddaughters (F2) and great-granddaughters (F3). Mammary 
tumorigenesis was higher in daughters and granddaughters of 
HF rat dams, and in daughters, granddaughters and great-
granddaughters of EE2 rat dams. Outcross experiments showed 
that increased mammary cancer risk was transmitted to HF 
granddaughters equally through the female or male germlines, 
but is only transmitted to EE2 granddaughters through the 
female germline.  Transgenerational effect on mammary cancer 
risk was associated with increased expression of DNA 
methyltransferases, and across all three EE2 generations hypo- 
or hyper-methylation of the same 375 gene promoter regions in 
their mammary glands. Our study shows that maternal dietary 
estrogenic exposures during pregnancy can increase breast 
cancer risk in multiple generations of offspring, and the increase 
in risk may be inherited through non-genetic means, possibly 
involving DNA methylation. 
I. INTRODUCTION 
Family history is a significant risk factor for breast cancer 
[1]. However, genetic mutations in high penetrance genes, such 
as BRCA1 and BRCA2, account only for a small proportion of 
familial breast cancers and despite intense search, no other 
major genetic mutations have emerged [2]. Thus, it is possible 
that many familial breast cancers may be transmitted not 
through inheritance of gene mutations, but mediated through 
other mechanisms, such as heritable epigenetic changes caused 
by in utero exposures. 
Maternal exposure during pregnancy to endocrine 
disrupting chemicals (EDC) and dietary factors has lasting 
effects on breast cancer risk among female offspring. We and 
others have shown in animal models that exposure to 
compounds, such as estradiol (E2) [3], diethylstilbestrol (DES), 
and high fat (HF) intake during pregnancy increases daughters’ 
(F1 generation) mammary cancer risk. Population studies also 
show that women who had high birth weight and daughters of 
women who took DES during their pregnancy are at increased 
breast cancer risk. Pregnant women are exposed daily to 
various environmental estrogenic compounds, and serum 
estrogens levels exhibit wide inter-individual variability among 
women undergoing a normal pregnancy [4].   
The adverse effects of in utero exposures on adult disease 
are likely mediated by epigenetic dysregulation, since the 
epigenome is most susceptible to perturbations in early 
development [5]. The precise epigenetic mechanisms involved 
are not known but likely involve DNA methylation, as 
demonstrated by some studies [6]. DNA methylation is 
catalyzed by DNA methyltransferases (DNMT): DNMT1 
maintains methylation patterns during cell division, while 
DNMT3a and 3b induce de novo methylation [7]. In utero 
exposures to endocrine disruptors alter the expression of DNA 
methyltransferases (DNMT1, 3a and 3b) in adult target tissues 
[8],   but whether these changes in DNMTs also take place in 
the mammary gland is unknown.  
More recent evidence suggests that some disease traits 
resulting from in utero exposures may be transmitted 
epigenetically through multiple generations [9]. Exposure of 
the developing male fetus to endocrine disruptors reduces 
fertility and causes prostate and kidney abnormalities that can 
persist for four consecutive generations [10]. 
In utero exposures can lead to multigenerational or 
transgenerational effects on disease risk.  Multigenerational 
effects are due to direct exposure of the F1 generation embryo 
and F2 generation germ-line present during gestation. These 
effects are not transmitted to the F3 generation. In contrast, 
transgenerational effects are observed in at least three 
generations and are due to germ-line transmission since the F3 
generation is not directly exposed to the environmental factor 
[11]. 
Here, we examined whether maternal exposures to HF diet 
or a synthetic E2 during pregnancy lead to multi or 
transgenerational inheritance of mammary cancer in a 
carcinogen-induced rat model of breast cancer. Our study 
shows for the first time that in utero exposures to EE2 and a HF 
diet can lead to trans- and multigenerational increase in the risk 
of breast cancer, respectively, without any further intervening 
exposures. The increase in breast cancer risk in the EE2 
offspring is associated with heritable DNA methylation 
patterns in the mammary glands of all three generations 
studied; suggesting that the transgenerational increase in 
mammary cancer risk involves epigenetic inheritance. If 
confirmed in humans, our findings represent a novel 
perspective on how breast cancer risk can be transmitted across 
generations and could have marked implications for breast 
cancer prevention and treatment. 
II. METHODS 
A. Genome-wide Identification of Significant Methylation 
Alteration (GISAIM) 
We developed a statistical approach, namely Genome-wide 
Identification of Significant Methylation Alteration (GISAIM), 
to identify the consistently inherited differential methylation 
patterns of genomic regions. In this study, we applied this 
method to identify the gene promoter regions that consistently 
show significant methylation changes in all three generations. 
Methylation intensity fold change is used to represent the 
differential methylation status. The total number of bases of 
short reads in a promoter is used to indicate the methylation 
intensity of that region. Based on this measure, we calculated 
the fold change of methylation intensity of the jth promoter in 
the ith generation by 
   𝑓𝑓𝑖𝑖,𝑗𝑗 = 𝑁𝑁𝐸𝐸𝐸𝐸2𝑖𝑖,𝑗𝑗+𝛽𝛽𝛽𝛽𝑁𝑁𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑖𝑖,𝑗𝑗+𝛽𝛽𝛽𝛽 ,   𝑖𝑖 = 1,2,3                   (1) 
where 𝑁𝑁𝐸𝐸𝐸𝐸2𝑖𝑖,𝑗𝑗  and 𝑁𝑁𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑖𝑖,𝑗𝑗  are the methylation intensities of 
EE2 group and control group, respectively, L is the short-read 
length which equals 36 in MDBCap-seq data, and 𝛽𝛽 is an offset 
parameter that suppresses the effects of weak methylation 
signals in the denominator. Here we set 𝛽𝛽 = 10. 
Further, we assessed the significance of the inherited 
differential methylation based on the methylation fold changes 
of all generation using GISAIM, to select promoters that have 
consistently large fold changes in all generations than would be 
expected by chance. 
B. GISAIM procedures 
GISAIM follows a hypothesis testing procedure to 
determine if methylation changes are significant and inherited. 
The summary statistics that reflecting the methylation 
change and inheritance is based on the methylation changes on 
promoter regions. We calculate the transformed fold change of 
all promoters by taking logarithm of the result of (1). 
𝐹𝐹𝑖𝑖,𝑗𝑗 = log2 � 𝑁𝑁𝐸𝐸𝐸𝐸2𝑖𝑖,𝑗𝑗+𝛽𝛽𝛽𝛽𝑁𝑁𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑖𝑖,𝑗𝑗+𝛽𝛽𝛽𝛽� ,   𝑖𝑖 = 1,2,3            (2) 
After the transformation, the fold change value become 
symmetric: a positive value indicates hyper-methylation and a 
negative value indicates hypo-methylation. 
The effects of multiple generations are summed into a 
consistent methylation score (M-score) for promoter j by the 
sum of fold changes 𝐹𝐹𝑖𝑖,𝑗𝑗, 
𝑀𝑀𝑗𝑗 = ∑ 𝐹𝐹𝑖𝑖,𝑗𝑗31                                     (3) 
This definition encourages large fold changes in each and 
all generations and consistent changes. Contradictory fold 
changes will cancel each other to produce a smaller M-score. 
Permutation test is carried out on the promoter labels within 
each generation and the M-scores for every promoter are 
recalculated. Suppose B permutations are used, then the B 
permuted M-scores of the jth promoter simulate the null 
distribution of 𝑀𝑀𝑗𝑗. 
Due to the potential unbalanced occurrence between hyper-
methylation and hypo-methylation, it is probable that the null 
distribution of 𝑀𝑀𝑗𝑗  is asymmetric in some chromosomes. 
Therefore, the permutation p-values of hyper-methylation and 
hypo-methylation are evaluated separately, i.e., one-sided test 
is used in each case. 
In this biological study, we find all promoters with p<0.002 
to form significant promoter set P. We use p-value cutoff of 
0.002 to select reasonable amount of promoters for 
visualization and further investigation. 
The promoters in set P represent the inherited hyper-
methylation and hypo-methylation induced by EE2 across three 
generations. An approach studying the genome-wide genetic 
aberrations without considering the inheritance is devised 
based on similar principles and has been successfully 
developed [12]. 
III. RESULTS AND DISCUSSION 
A. Genome-wide methylation profiling 
Genomic DNA (n=3/group) was isolated using the Wizard® 
Genomic DNA Purification Kit (Promega, Madison, WI). 
Methylated DNA was eluted by the MethylMiner Methylated 
DNA Enrichment Kit (Invitrogen). Briefly, one microgram of 
genomic DNA was sheared by sonication and captured by 
MBD proteins. The methylated DNA was eluted and used to  
generate Methyl-CpG binding domain-based capture 
(MDBCap) libraries, as previously described. MBDCap 
coupled with massively parallel sequencing (MBDCap-seq) 
libraries were sequenced using the Illumina Genome Analyzer 
II (GA II). Image analysis and base calling were performed 
with the standard Illumina pipeline. Sequencing reads were 
mapped by ELAND algorithm. Statistical analyses of 
methylation patterns across generations were focused on the 
gene promoter regions defined as up to 5000 base pairs 
upstream of transcription starting site. The CpG islands within 
the promoter regions were identified as previously described. 
B. Increased breast cancer risk in multiple generations of 
offspring 
To test our hypothesis that maternal exposures during 
pregnancy to factors such as HF diet or a synthetic E2 lead to 
breast cancer in multiple generations, we fed pregnant Sprague-
Dawley rats (F0) either a AIN93G control diet or an isocaloric 
AIN93G based HF diet, containing 43% energy from corn oil, 
throughout gestation. Another group of pregnant rats was fed 
AIN93G diet supplemented with 0.1ppm ethinyl estradiol 
(EE2) from day 14 to day 20 of pregnancy. F1 females were 
mated with F1 males from the same group to produce the F2 
generation. The F3 generation was produced in the same 
manner.  No sibling mating was carried out.  The F1, F2 and F3 
offspring were maintained on the AIN93G control diet for the 
duration of the experiment. 
 
Figure 1. Multigenerational effect of maternal HF diet. 
 
Figure 2. Transgenerational effect of maternal EE2-
supplemented diet. 
Effects of HF or EE2 exposure on pregnant F0 dams on 
mammary cancer risk in the F2 and F3 generations were then 
examined. In the HF granddaughters (F2 generation) mammary 
tumor incidence (p=0.028), but not multiplicity (p=0.38), was 
higher compared to the control group (Fig. 1c,d). Mammary 
tumor incidence did not differ (p=0.33) between the control 
and HF great-granddaughters (F3 generation), however, tumor 
multiplicity was lower (p=0.013) in the HF offspring. In the 
EE2 granddaughters (F2 generation), neither tumor incidence 
(p=0.68) nor multiplicity (p=0.49) was statistically different 
from the controls (Fig. 1e,f). However, EE2 great-
granddaughters (F3 generation) had significantly higher tumor 
multiplicity (p=0.038) compared to controls (Fig. 2c,d). 
Mammary tumor incidence was also higher, but not statistically 
significant (p=0.07) in the EE2 F3 generation compared to 
controls. Histopathologic analysis indicated that the majority of 
mammary tumors across all three groups were malignant 
(adenocarcinomas or solid carcinomas). 
To investigate whether mammary cancer risk could be 
transmitted either through the female or male lineages, we 
mated F1 unexposed males to F1 exposed females or F1 
unexposed females to F1 unexposed males. Mammary tumor 
incidence was higher in both HF F2 outcross groups (HF 
(female)xCon(male): 68%; and Con(female)xHF(male): 69%) 
compared to controls (50%), but did not reach statistical 
significance (p=0.44) (Fig. 1g). These results, however, suggest 
that the effects of HF in utero exposure on mammary cancer 
risk can be transmitted through both the female or male 
germlines. EE2 outcross experiments show that only 33% of 
offspring resulting from Con(female)xEE2(male) male 
breeding developed mammary tumors, whilst 62% of the 
female EE2(female)xCon(male) offspring developed mammary 
tumors (Fig. 2g). Levels of tumor multiplicity were 
significantly higher in the EE2xCon outcross group compared 
to controls (p=0.013) (Fig. 2h). Thus, unlike HF, EE2 exposure 
had an opposite effect on developing male and female fetuses 
regarding their ability to transmit susceptibility to mammary 
cancer to their offspring.  
C. Altered mammary gland DNA methylation patterns in 
three generations of offspring. 
We then determined whether the increase in Dnmt1 and 
Dnmt3a/3b expression in the mammary glands of EE2 
offspring was associated with differential DNA methylation 
patterns by using Methyl-CpG Binding domain-based Capture 
and sequencing (MDBCap-seq) method. Using GISAIM, we 
examined whether any promoter regions that were 
differentially methylated between control and EE2 offspring in 
F1, F2 or F3 generations were common across all three 
generations. This analysis resulted in the identification of 375 
differentially methylated gene promoter regions across the 21 
chromosomes, among which 214 were hyper-methylated and 
161 are hypo-methylated in the F1-F3 generation EE2 
offspring. 
 
Figure 3. Differential promoter methylation in mammary 
glands of EE2 offspring. 
Fig. 3a are the heat maps of differentially methylated gene 
promoter regions in EE2 offspring (green, n=3) compared with 
controls (red, n=3). Hyper-methylation and hypo-methylation 
are presented separately. mBDCap-seq method was used to 
access DnA methylation levels. Further analysis showed that 
five of the hyper-methylated promoter regions were associated 
with polycomb target genes (PcTGs: Pax6, Runx3, Foxe3, 
Gata4, Vgf) linked to stem cell differentiation and cancer. Fig. 
3b shows that promoter methylation levels of the polycomb 
target genes (PcTGs) Foxe3, Gata4, Pax6, Runx3 and Vgf on 
PnD50 rat mammary glands of F1–F3 generation female 
offspring of Sprague-Dawley rat dams (F0) fed EE2 or control 
diet during gestation. Data are presented as relative intensity of 
methylation (mean±s.e.m., n=3 per group). P<0.05 is 
considered significant; exact p-values are shown in each plot. 
To visually compare the inherited methylation changes of 
EE2 and control, we plot the methylation profiles of the 375 
significant promoters of chromosomes 1 and X in Fig. 4 as 
examples. The chromosomes are represented by a compact 
view by concatenating the significant promoters while leaving 
remaining genomic regions out to obtain a distinguishable 
resolution. The horizontal axis index is base pair, and the 
vertical axis index is methylation count. Promoters are 
separated by dashed vertical lines. The start position and end 
position of the promoter are marked at the top-left and bottom-
right of the promoter region respectively. The gene name is 
marked at the bottom-left of the promoter region. To facilitate 
the comparison, the control group is plotted under 0 by taking 
the opposite value. The solid blue line is the averaged 
methylation profile of EE2, and the solid red line is the 
averaged methylation profile of control. Regions in pink 
background indicate hyper-methylation and regions in light 
purple background indicate hypo-methylation. The CpG islands 
within the promoter regions are highlighted in the plot using 
dark green rectangles. We can see many methylation events are 
overlapped with CpG islands. 
 
 
Figure 4. Inherited differentially methylated gene promoters of 
chromosomes 1 (upper) and X (lower). 
IV. CONCLUSION 
 Our statistical analyses of methylation patterns across 
generations are focused on the gene promoter regions defined 
as up to 5000 base pairs upstream of transcription starting site. 
To explicitly account for the background rate of random 
methylations and to distinguish meaningful events from 
random background methylations. GISAIM identifies regions 
of methylation change that are more likely to drive cancer risk 
across generations than would be expected by chance. In the 
breast cancer risk inheritance study, GISAIM identifies 
significant inheritable methylation changes between EE2+/- 
mice through two key steps. First, the method calculates a 
statistic that involves both the frequency and amplitude of the 
methylation change with methylation intensity being the counts 
of mapped methylation short reads within each of the gene 
prompter regions. Second, it assesses the statistical significance 
of each promoter methylation change using a positional 
permutation test that is based on the overall pattern of 
methylation changes seen across the gene promoter regions. 
GISAIM reveals a highly concordant inheritability picture 
involving 375 significant events (P<0.002), including both 
hyper-methylation and hypo-methylation changes in gene 
promoter regions. We also found many significant events 
(P<0.05) that are associated with well-known cancer risk genes 
or the CpG islands within these promoter regions. 
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